Gulla S, Sharma T, Gardner E, Li C, Purohit TA, Xue C, Colligan S, Shyam Sundar S, Yang B, Trostel SY, Capaldo B, Bard JE, Ogunbowale T, Jawadwala A, Ma M, Qu J, Karzai F, Pili R, Jarrard DF, Sowalsky AG, VanderWeele DJ, Adelaiye-Ogala R. (2026) MECOM Function is Critical for AR-Driven Treatment-Resistant Prostate Cancer. Cancer research (Jan).
Shen Q, Wang H, Roco JA, Meng X, Bosticardo M, Hodges M, Battaglia M, Feng ZP, Talks BJ, Powell J, Shanmugiah VBM, Chu J, Rahman NM, Elsheikh A, Chakravarty P, Grenov A, Emmerich M, Delmonte OM, Freeman AF, Keller MD, Belaid B, Papa I, Lee JC, Cañete PF, Gonzalez-Figueroa P, Zhang Y, Xue HH, Turajlic S, Notarangelo LD, Haniffa M, Garrett-Sinha LA, Parry HM, Kanellakis NI, Vinuesa CG. (2025) Publisher Correction: TCF1 and LEF1 promote B-1a cell homeostasis and regulatory function.
Shen Q, Wang H, Roco JA, Meng X, Bosticardo M, Hodges M, Battaglia M, Feng ZP, Talks BJ, Powell J, Shanmugiah VBM, Chu J, Rahman NM, Elsheikh A, Chakravarty P, Grenov A, Emmerich M, Delmonte OM, Freeman AF, Keller MD, Belaid B, Papa I, Lee JC, Cañete PF, Gonzalez-Figueroa P, Zhang Y, Xue HH, Turajlic S, Notarangelo LD, Haniffa M, Garrett-Sinha LA, Parry HM, Kanellakis NI, Vinuesa CG. (2025) TCF1 and LEF1 promote B-1a cell homeostasis and regulatory function. Nature (Oct), 646(8084): 442-451.
Nmezi B, Bey GR, Oranburg TD, Dudnyk K, Lardo SM, Herdman N, Jacko A, Rubio S, Alcocer EL, Kofler J, Kim D, Rankin J, Kivuva E, Gutowski N, Schon K, van den Ameele J, Chinnery PF, Sousa SB, Palavra F, Toro C, Pinto E Vairo F, Saute J, Pan L, Alturkustani M, Hammond R, Gros-Louis F, Gold M, Park Y, Bernard G, Raininko R, Zhou J, Hainer SJ, Padiath QS. (2025) An oligodendrocyte silencer element underlies the pathogenic impact of lamin B1 structural variants. Nature Communications (Feb), 16(1): 1373.
Tong X, Patel AS, Kim E, Li H, Chen Y, Li S, Liu S, Dilly J, Kapner KS, Zhang N, Xue Y, Hover L, Mukhopadhyay S, Sherman F, Myndzar K, Sahu P, Gao Y, Li F, Li F, Fang Z, Jin Y, Gao J, Shi M, Sinha S, Chen L, Chen Y, Kheoh T, Yang W, Yanai I, Moreira AL, Velcheti V, Neel BG, Hu L, Christensen JG, Olson P, Gao D, Zhang MQ, Aguirre AJ, Wong KK, Ji H. (2024) Adeno-to-squamous transition drives resistance to KRAS inhibition in LKB1 mutant lung cancer. Cancer cell (Mar), 42(3): 413-428.e7.